3 -5 (91) 2026 - M.B. Istamov, Kh.K. Mukhtorova - DEPRESSIVE DISORDERS IN TYPE 2 DIABETES: CURRENT STATUS OF THE PROBLEM, CLINICAL SIGNIFICANCE AND APPROACHES TO DIAGNOSTICS

DEPRESSIVE DISORDERS IN TYPE 2 DIABETES: CURRENT STATUS OF THE PROBLEM, CLINICAL SIGNIFICANCE AND APPROACHES TO DIAGNOSTICS

M.B. Istamov - Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Medical University

Kh.K. Mukhtorova - Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Medical University

Sh.Sh. Magzumova - Bukhara State Medical Institute named after Abu Ali ibn Sina, Tashkent State Medical University

Resume

Type 2 diabetes mellitus is one of the most common chronic noncommunicable diseases, characterized by a high risk of complications, reduced quality of life, and significant medical and social burden. Depressive disorders occupy a special place among comorbid conditions in type 2 diabetes, occurring significantly more frequently in this category of patients than in the general population and significantly impacting the disease course, glycemic control, treatment adherence, and prognosis. This article presents an overview of current data on depressive disorders in type 2 diabetes, examining the bidirectional relationships between diabetes and depression, the clinical significance of affective symptoms in diabetology, the challenges of differential diagnosis, and current approaches to psychosocial screening and clinical verification of depression. It is demonstrated that depression in patients with type 2 diabetes should not be considered a secondary emotional reaction to a chronic disease, but rather as an independent clinically significant factor requiring active identification and inclusion in a comprehensive, interdisciplinary patient management system.

Key words: type 2 diabetes mellitus, depressive disorders, comorbidity, glycemic control, treatment adherence, quality of life, diagnostics.

First page

18

Last page

25

For citation:M.B. Istamov, Kh.K. Mukhtorova, Sh.Sh. Magzumova - DEPRESSIVE DISORDERS IN TYPE 2 DIABETES: CURRENT STATUS OF THE PROBLEM, CLINICAL SIGNIFICANCE AND APPROACHES TO DIAGNOSTICS//New Day in Medicine 5(91)2026 18-25 https://newdayworldmedicine.com/en/new_day_medicine/5-91-2026

List of References

1. Восиков Б. А., Магзумова Ш. Ш. Сравнительная динамика тревожно-депрессивной симптоматики у пациентов с различными формами гипотиреоза // Медицинский журнал молодых ученых. 2025. № 16(12). С. 42–46.
2. Ajele KW, Idemudia ES. The role of depression and diabetes distress in glycemic control: A meta-analysis. Diabetes Res Clin Pract. 2025;221.
3. American Diabetes Association Professional Practice Committee. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes—2025. Diabetes Care. 2024;48(Suppl 1):S86–S127.
4. American Diabetes Association Professional Practice Committee. Summary of Revisions: Standards of Care in Diabetes—2025. Diabetes Care. 2024;48(Suppl 1):S6–S13.
5. Berk M, et al. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023;22(3):366–387.
6. Beverly EA, Gonzalez JS. The interconnected complexity of diabetes and depression. Diabetes Spectr. 2025;38(1):23–31.
7. Centers for Disease Control and Prevention (CDC). Diabetes and mental health [Internet]. Available from: https://www.cdc.gov/diabetes/living-with/mental-health.html (cited 2026 Mar 12).
8. Farooqi A, et al. A systematic review and meta-analysis to compare the prevalence of depression between people with and without Type 1 and Type 2 diabetes. Prim Care Diabetes. 2022;16(1):1–10.
9. Gonzalez JS, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–2403.
10. Grenard JL, et al. Depression and medication adherence in the treatment of chronic diseases in the United States: a meta-analysis. J Gen Intern Med. 2011;26(10):1175–1182.

    file

    download